Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:4 Issue:6 Number:54 ISSN#:2563-5476
RCT
ACE Report #7876
Ace Report Cover Arthroplasty

ISAKOS 2015: Arthroscopic arthroplasty superior to debridement for knee OA pain & function


How to Cite

OrthoEvidence. ISAKOS 2015: Arthroscopic arthroplasty superior to debridement for knee OA pain & function. ACE Report. 2015;4(6):54. Available from: https://myorthoevidence.com/AceReport/Report/7876

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Arthroscopic Arthroplasty Versus Debridement for Knee Osteoarthritis in Patients Without Malalignment or Mechanical Symptoms

Contributing Authors: Jinzhong Zhao

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

284 participants with knee osteoarthritis (OA) were randomized to undergo arthroscopic arthroplasty (AA) or arthroscopic debridement (AD). The purpose of this study was to explore any differences in outcome between AA and AD in patients with moderate-to-severe knee OA over 60 months postoperatively. Results demonstrated that AA offered a significant increase in functional score (Western Ontario an...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.